CNS Biomarkers

CNS Biomarkers are utilized as a part of clinical research and in clinical practice as a quantifiable marker of an ordinary neurological condition, sick state or pharmacologic reaction to a remedial intercession. CNS biomarkers incorporate neuroimaging biomarkers, CSF biomarkers, and therefore the a part of biomarkers in determination and drugs improvement.

  • Risk Assessment
  • Screening/Detection

Related Conference of CNS Biomarkers

May 30-31, 2024

2nd International conference on Neuro Surgery

Vienna, Austria
June 13-14, 2024

37th European Neurology Congress 2024

Rome, Italy
June 27-28, 2024

2nd International conference on Dementia

London, UK
June 27-28, 2024

6th World Depression Congress

Paris, France
July 15-16, 2024

7th World Conference on Neuroscience

London, UK
July 18-19, 2024

36th World Conference on Neurology

Paris, France
August 13-14, 2024

14th Global Alzheimers Summit

Amsterdam, Netherlands
August 16-17, 2024

30th Annual Summit on Neuroscience & Neurological Disorders

Melbourne, Australia
September 19-20, 2024

38th European Neurology Congress

Paris, France
September 23-24, 2024

11th Annual congress on Stroke and Neurological Disorders

Amsterdam, Netherlands
October 23-24, 2024

6th World Brain Congress

Paris, France
October 31-01, 2024

7th Global Congress on Spine and Spinal Disorders

Amsterdam, Netherlands
October 31-01, 2024

36th World Neuroscience and Neurology Conferences

Amsterdam, Netherlands
November 13-14, 2024

31st Cognitive Neuroscience Congress

Dubai, UAE
November 26-27, 2024

4th Annual Dementia Congress

Paris, France
December 05-06, 2024

7th World Congress on Epilepsy and Brain Disorders

Dubai, UAE
December 05-06, 2024

9th Annual Congress on Pediatric Neurology and Pediatric Surgery

Prague, Czech Republic

CNS Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in